We are moving! DermSurgery Associates' main office is moving! On November 27, 2023, we will open our doors at 6700 W. Loop South, Suites 450 & 500, Bellaire, TX 77401! We will no longer be seeing patients at our 7515 Main Street location. We will have 2 convenient locations to serve you: DermSurgery Associates 6700 …
DermSurgery Associates was honored to receive a very limited number of COVID-19 vaccines that we administered to our physicians, nurses, employees, patients who are healthcare workers, and highest-risk patients. We were able to have the greatest impact on our community by vaccinating our healthcare workers and patients who are healthcare workers, allowing us to keep …
DermSurgery Associates is a network of highly trained Houston dermatologists offering industry-leading, advanced treatments for a wide range of skin conditions. These highly trained Houston dermatologists and their talented support staff specialize in cosmetic dermatology, adult and pediatric dermatology and skin cancer surgery and treatment. With 11 service locations conveniently located across the Houston-metropolitan area, …
Internationally renowned Houston dermatology and Mohs Surgery expert Leonard Goldberg, M.D. is a fellow of the Royal College of Physicians. He founded DermSurgery Associates on the belief that patients should be provided with the best care possible from a caring and knowledgeable team. Collectively, their expert staff of 18 highly-trained doctors has more than 250 …
A diagnosis of skin cancer is no laughing matter. Whether it's common basal cell carcinoma or resistant melanoma, the condition must be promptly addressed. Mohs skin cancer surgery is the treatment that Houston-based DermSurgery Associates recommends for most patients. May is Skin Cancer Awareness Month, so this is a good time to learn a little …
Is it time for a professional cancer screening? In the United States in 2013, an estimated 1,660,290 new cases of cancer were diagnosed. The American Cancer Society estimates that 580,350 of these cases will end in death. The society projects that melanoma skin cancer accounted for 76,690 of the newly diagnosed cancer cases, with 9,480 …
Houston, TX - February 3, 2012 - Genentech announced that Erivedge ™ (vismodegib) capsule was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with basal cell carcinoma (BCC, a type of skin cancer.) Erivedge™ was approved on January 30, 2012. Dr. Leonard H. Goldberg, a Houston Dermatological surgeon, has …